OncBioMune Pharmaceuticals

About

OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. The company has proprietary Vaccine Technology designed to stimulate the immune system to attack cancer while protecting healthy tissue. Their lead product ProscaVax is undergoing clinical trials for prostate cancer treatment, representing innovative approaches to cancer immunotherapy.